![Martin Huber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 1 M $ in data 31/05/2026
Martin H.
Huber is currently an Independent Director at Syndax Pharmaceuticals, Inc. since 2021 and an Independent Director at Actuate Therapeutics, Inc. starting in 2026.
Former positions include President, Chief Executive Officer & Director at Mersana Therapeutics, Inc. from 2023 to 2026; President, Head-Research & Development at Xilio Therapeutics, Inc. from 2022 to 2023; Senior Vice President-Clinical at GSK Plc from 2019 to 2020; Chief Medical Officer & Senior Vice President at Tesaro, Inc. from 2015 to 2019; Vice President-Oncology Clinical Research at Merck Research Laboratories Massachusetts LLC from 2012 to 2015; Vice President-Global Pharmacovigilance at Schering-Plough Corp.; Assistant Professor at The University of Texas M.D.
Anderson Cancer Center.
Education includes undergraduate studies at Texas Lutheran University and a doctorate from Baylor College of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/03/2026 | 74.000 ( 0,08% ) | 1 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 15/09/2021 |
| ACTUATE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/05/2026 |
| Società | Posizione | Fine |
|---|---|---|
| MERSANA THERAPEUTICS | Amministratore Delegato | 06/01/2026 |
| XILIO THERAPEUTICS, INC. | Presidente | 08/09/2023 |
| GSK PLC | Direttore Tecnico/Scientifico/R&S | 01/04/2020 |
| TESARO INC | Direttore Tecnico/Scientifico/R&S | 22/01/2019 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | 01/01/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Texas Lutheran University
 Texas Lutheran University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel therapeutics which target cancers and neurodegenerative diseases | Health Technology |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
